PubRank

D K Bishop

Author PubWeight™ 78.84‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Mitotic phosphorylation of histone H3 is governed by Ipl1/aurora kinase and Glc7/PP1 phosphatase in budding yeast and nematodes. Cell 2000 6.81
2 Adoptive transfer of immunity to Listeria monocytogenes. The influence of in vitro stimulation on lymphocyte subset requirements. J Immunol 1987 6.75
3 The breast cancer susceptibility gene BRCA1 is required for subnuclear assembly of Rad51 and survival following treatment with the DNA cross-linking agent cisplatin. J Biol Chem 2000 4.49
4 A meiotic recombination checkpoint controlled by mitotic checkpoint genes. Nature 1996 3.66
5 Rad52 associates with RPA and functions with rad55 and rad57 to assemble meiotic recombination complexes. Genes Dev 1998 2.77
6 The role of heteroduplex correction in gene conversion in Saccharomyces cerevisiae. Nature 1987 2.38
7 Tid1/Rdh54 promotes colocalization of rad51 and dmc1 during meiotic recombination. Proc Natl Acad Sci U S A 2000 2.28
8 Saccharomyces cerevisiae recA homologues RAD51 and DMC1 have both distinct and overlapping roles in meiotic recombination. Genes Cells 1997 2.18
9 Repair of heteroduplex plasmid DNA after transformation into Saccharomyces cerevisiae. Mol Cell Biol 1986 1.98
10 Assembly of RecA-like recombinases: distinct roles for mediator proteins in mitosis and meiosis. Proc Natl Acad Sci U S A 2001 1.97
11 Structural relationship of bacterial RecA proteins to recombination proteins from bacteriophage T4 and yeast. Science 1993 1.83
12 Saccharomyces cerevisiae checkpoint genes MEC1, RAD17 and RAD24 are required for normal meiotic recombination partner choice. Genetics 1999 1.82
13 Meiotic chromosome metabolism: one view. Cold Spring Harb Symp Quant Biol 1991 1.71
14 Saccharomyces cerevisiae Dmc1 protein promotes renaturation of single-strand DNA (ssDNA) and assimilation of ssDNA into homologous super-coiled duplex DNA. J Biol Chem 2001 1.61
15 Connective tissue growth factor promotes fibrosis downstream of TGFbeta and IL-6 in chronic cardiac allograft rejection. Am J Transplant 2009 1.59
16 Rapid activation-independent shedding of leukocyte L-selectin induced by cross-linking of the surface antigen. Eur J Immunol 1992 1.42
17 In vivo depletion of CD8+ T cells results in Th2 cytokine production and alternate mechanisms of allograft rejection. Transplantation 1995 1.26
18 Alloantigen-reactive Th1 development in IL-12-deficient mice. J Immunol 1998 1.23
19 IL-12 antagonism induces T helper 2 responses, yet exacerbates cardiac allograft rejection. Evidence against a dominant protective role for T helper 2 cytokines in alloimmunity. J Immunol 1996 1.22
20 Nine novel conserved motifs in BRCA1 identified by the chicken orthologue. Oncogene 2001 1.20
21 Differential effects of IL-12 receptor blockade with IL-12 p40 homodimer on the induction of CD4+ and CD8+ IFN-gamma-producing cells. J Immunol 1997 1.17
22 Enhanced T cell engraftment after retroviral delivery of an antiviral gene in HIV-infected individuals. Proc Natl Acad Sci U S A 1998 1.17
23 Critical role for IL-6 in hypertrophy and fibrosis in chronic cardiac allograft rejection. Am J Transplant 2009 1.13
24 Inflammation-induced endothelial cell adhesion to lymphocytes, neutrophils, and monocytes. Role of homing receptors and other adhesion molecules. Transplantation 1989 1.11
25 Inhibition of the alloantibody response by CD95 ligand. Nat Med 1997 1.10
26 Inducible expression of an endothelial cell antigen on murine myocardial vasculature in association with interstitial cellular infiltration. Transplantation 1989 1.03
27 Type 1 versus type 2 cytokine release by Vbeta T cell subpopulations determines in vivo antitumor reactivity: IL-10 mediates a suppressive role. J Immunol 1997 1.01
28 Are Th2 helper T lymphocytes beneficial, deleterious, or irrelevant in promoting allograft survival? Transplantation 1997 0.99
29 Immune response in human melanoma after transfer of an allogeneic class I major histocompatibility complex gene with DNA-liposome complexes. Proc Natl Acad Sci U S A 1996 0.99
30 The classical complement pathway in transplantation: unanticipated protective effects of C1q and role in inductive antibody therapy. Am J Transplant 2008 0.92
31 Immunogenetic therapy of human melanoma utilizing autologous tumor cells transduced to secrete granulocyte-macrophage colony-stimulating factor. Hum Gene Ther 2000 0.91
32 Cytokine regulation of chronic cardiac allograft rejection: evidence against a role for Th1 in the disease process. Transplantation 1999 0.90
33 Tissue-specific consequences of the anti-adenoviral immune response: implications for cardiac transplants. Nat Med 1999 0.90
34 DNA-liposome versus adenoviral mediated gene transfer of transforming growth factor beta1 in vascularized cardiac allografts: differential sensitivity of CD4+ and CD8+ T cells to transforming growth factor beta1. Transplantation 2000 0.90
35 Transforming growth factor beta-induced connective tissue growth factor and chronic allograft rejection. Am J Transplant 2006 0.90
36 Lipid-mediated gene transfer of viral IL-10 prolongs vascularized cardiac allograft survival by inhibiting donor-specific cellular and humoral immune responses. Gene Ther 1998 0.88
37 Lysis of adult ventricular myocytes by cells infiltrating rejecting murine cardiac allografts. Circulation 1996 0.88
38 Interleukin-12 (IL-12)-driven alloimmune responses in vitro and in vivo: requirement for beta1 subunit of the IL-12 receptor. Transplantation 1999 0.87
39 Transplant acceptance following anti-CD4 versus anti-CD40L therapy: evidence for differential maintenance of graft-reactive T cells. Am J Transplant 2008 0.86
40 Tolerance induction by anti-CD2 plus anti-CD3 monoclonal antibodies: evidence for an IL-4 requirement. J Immunol 1998 0.86
41 Gene transfer of virally encoded chemokine antagonists vMIP-II and MC148 prolongs cardiac allograft survival and inhibits donor-specific immunity. Gene Ther 2000 0.84
42 Evidence that human cardiac allograft acceptance is associated with a decrease in donor-reactive helper T lymphocytes. Transplantation 1995 0.84
43 Development and evaluation of a limiting dilution analysis technique that can discriminate in vivo alloactivated cytotoxic T lymphocytes from their naive CTL precursors. Transplantation 1989 0.83
44 BRCA2 and homologous recombination. Breast Cancer Res 2001 0.83
45 Restricted V beta usage by T cells infiltrating rejecting human lung allografts. J Immunol 1996 0.80
46 T cell receptor (TCR) repertoire in alloimmune responses. Int Rev Immunol 1996 0.80
47 Direct transfer of a foreign MHC gene into human melanoma alters T cell receptor V beta usage by tumor-infiltrating lymphocytes. Cancer Immunol Immunother 1996 0.79
48 DNA sequences required for hormonal induction of rat alpha 2u-globulin genes. Cold Spring Harb Symp Quant Biol 1983 0.79
49 Adoptive immunotherapy of cancer with activated lymph node cells primed in vivo with autologous tumor cells transduced with the GM-CSF gene. Hum Gene Ther 1996 0.79
50 Effects of growth rate on carcass composition and lipid partitioning at puberty and growth hormone, insulin-like growth factor I, insulin, and metabolites before puberty in beef heifers. J Anim Sci 1995 0.78
51 In vivo mechanisms of alloreactivity. VI. Evidence that alloantigen deposition initiates both local and systemic mechanisms that influence CTL accumulation at a graft site. Transplantation 1989 0.78
52 Relationship between leukocytic infiltration and endothelial specialization in murine cardiac allografts. Hum Immunol 1990 0.78
53 Direct and indirect effects of murine interleukin-2, gamma interferon, and tumor necrosis factor on testosterone synthesis in mouse Leydig cells. J Androl 1992 0.78
54 Analysis of retinoid-mediated immunosuppression in vivo. Effects of Ro23-6457 on cellular alloimmune responses. Immunopharmacology 1992 0.77
55 Allogeneic class I MHC requirement for alloantigen-reactive helper T-lymphocyte responses in vivo. Evidence for indirect presentation of alloantigen. Transplantation 1996 0.75
56 Genetic vaccination-induced immune responses to the human immunodeficiency virus protein Rev: emergence of the interleukin 2-producing helper T lymphocyte. Hum Gene Ther 1998 0.75
57 Limiting dilution analysis of alloreactive T-cell status and distribution during allograft rejection. Hum Immunol 1990 0.75
58 Regulation of cardiac allograft rejection by T lymphocytes. Trends Cardiovasc Med 1996 0.75
59 In vivo mechanisms of alloreactivity. V. Influence of graft implantation on the activation and redistribution of graft-reactive CTL. Transplantation 1989 0.75